Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

Search Results


  • This unit treats all types of cancer, including leukaemia, lymphoma, solid tumours, as well as brain and spinal cord tumours, in children and young people aged from 1–24 years

  • Having cancer can be an uncertain time, but with the support of our consultants, healthcare advisors and nurses you can feel reassured. Learn about John’s experience at The Royal Marsden Private Care.

  • Cancer is a complex disease, requiring first-rate diagnosis, treatment and care. When it comes to making life-changing decisions, you want to be treated for the very best. This is where The Royal Marsden Private Care is like no other.

  • Any patient, carer or member of the public can become involved with the research we undertake at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. 

  • Discovering that you have cancer, and needing to come into hospital, is a very worrying and stressful time. We know that anxiety about healthcare-associated infections such as MRSA or C. difficile can add to your worries.

  • We would like to invite you to a state of the art one day virtual symposium focusing on recent advances in the diagnosis and treatment of lung cancer and mesothelioma.

  • Paperwork-heavy clinical trial management is set to be revolutionised by a unique collaboration between Hyland content services provider and researchers at specialist cancer hospital The Royal Marsden NHS Foundation Trust.

  • The Outreach, Symptom and Palliative Care Service provides support, advice and symptom management advice to children and young people (and their parents/carers) who are aged between 1 and 19 years, have cancer and have been referred to the Children and Young People's Unit at The Royal Marsden.

  • The Biomedical Research Centre Generic Biobank was set up to serve as an important core resource to collect clinically relevant samples and make them available to researchers for both basic and translational studies. It facilitates research programmes aimed at identifying and developing new personalised treatments for cancer.

  • The study day will give delegates the opportunity to explore the current immunotherapy landscape and the role of CAR-T as a systemic anti cancer therapy. The day will raise awareness of the complex patient pathway and the myriad challenges experienced by patients, carers, and the service.